Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Clarivate sells information, analytics, and software that help researchers, universities, drug companies, and patent lawyers find and organize trustworthy knowledge.
Clarivate is in the business of knowing things and proving it. It sells subscriptions to databases, analytics, and workflow software that help universities, governments, drugmakers, and patent attorneys find reliable information, track who cited whose work, and manage the paperwork that proves an idea is new. Think of it as the referee and record keeper for the world's ideas — deciding which journals count as credible, which patents exist, and which research is worth building on.
The crown jewel is the Web of Science, a citation index that for decades has been a default way to measure research quality, feeding things like journal impact factors that academics love and complain about in equal measure. It also owns ProQuest, a huge archive of dissertations, newspapers, and scholarly content that libraries license. On the patent side, its tools help companies and law firms search prior art and manage intellectual property portfolios. In life sciences, it sells data and software that help drug companies track competitors, find partners, and navigate clinical trials. Customers pay recurring subscription fees, which sounds cozy, but Clarivate has had a bumpy stretch. It went public in 2019 and grew fast by buying businesses like ProQuest and the intellectual property firm CPA Global, piling on debt. Growth has since slowed, the stock has fallen hard from its pandemic-era highs, and management has been cutting costs and reshaping the portfolio. The company has a new chief executive, has been trimming debt, and in 2024 announced plans to sell its life sciences and healthcare intelligence unit to a private equity buyer, narrowing the business back toward academia and intellectual property.
The bet underneath it all is that institutions will keep paying for trustworthy, curated information even when the internet is full of free noise — a real moat, since a citation index is only useful if everyone agrees to use the same one. The risk is that AI tools make it easier to gather and judge information without a middleman, that library budgets are tight, and that a big debt load limits room to maneuver. Clarivate's job is to convince its customers that its curated record is still the one worth paying for.
Saved answer · last researched 15 Nov 2026